Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | BIIB | RPRX | ||
| Company | Horizon Therapeutics | Biogen Inc | Royalty Pharma Plc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 116.34 | 193.51 | 45.26 | ||
| High | 116.38 | 195.00 | 45.27 | ||
| Low | 116.26 | 191.86 | 44.68 | ||
| Latest | 116.30 | 191.27 | 45.06 | ||
| Change | +0.05 | -2.86 | -0.28 | ||
| % Change | +0.04% | -1.47% | -0.62% | ||
| Volume | 28,881,200 | 165,682 | 532,044 | ||
| 20-Day Average Volume | 3,994,490 | 1,449,942 | 3,841,760 | ||
| Previous Close | 116.25 | 194.13 | 45.34 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 184.96 | 43.03 | ||
| 20-Day Raw Stochastic | 95.09% | 67.89% | 82.67% | ||
| 20-Day Relative Strength | 80.29 | 58.18 | 70.38 | ||
| Weighted Alpha | +49.30 | +46.79 | +41.10 | ||
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 40% Buy | 56% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | +0.43% since 02/11/26 | +1.72% since 02/11/26 | ||
| Low | 115.66 on 09/29/23 | 189.00 on 02/12/26 | 44.05 on 02/12/26 | ||
| High | 116.38 on 10/05/23 | 200.29 on 02/17/26 | 46.14 on 02/17/26 | ||
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | +16.78% since 01/16/26 | +13.81% since 01/16/26 | ||
| Low | 114.75 on 09/11/23 | 160.36 on 01/20/26 | 38.86 on 01/20/26 | ||
| High | 116.38 on 10/05/23 | 202.41 on 02/06/26 | 46.14 on 02/17/26 | ||
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | +14.34% since 11/19/25 | +16.46% since 11/19/25 | ||
| Low | 98.80 on 08/03/23 | 160.36 on 01/20/26 | 37.31 on 11/24/25 | ||
| High | 116.38 on 10/05/23 | 202.41 on 02/06/26 | 46.14 on 02/17/26 | ||
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | +38.28% since 08/19/25 | +25.03% since 08/19/25 | ||
| Low | 90.56 on 05/16/23 | 131.52 on 08/29/25 | 34.08 on 09/08/25 | ||
| High | 116.38 on 10/05/23 | 202.41 on 02/06/26 | 46.14 on 02/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 28,490,324 | 26,171,970 | ||
| Shares Outstanding, K | 228,995 | 146,759 | 577,238 | ||
| Annual Sales | 3,629,040,000 | 9,890,600,000 | 2,378,190,000 | ||
| Annual Net Income | 521,480,000 | 1,292,900,000 | 770,950,000 | ||
| Last Quarter Sales | 944,960,000 | 2,279,400,000 | 621,990,000 | ||
| Last Quarter Net Income | 127,070,000 | -48,900,000 | 214,210,000 | ||
| 60-Month Beta | 1.03 | 0.16 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | 1.99 on 02/06/26 | 1.17 on 11/05/25 | ||
| Latest Earnings Date | 11/01/23 | 05/07/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | 0.235 on 02/20/26 | ||
| Next Ex-Dividends Date | N/A | N/A | 02/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 12.79 | 9.40 | ||